首页> 外文会议>American Peptide Symposium >The Effects of Protein Kinase C (PKC) Epsilon Peptide Regulation on Endothelial Nitric Oxide Synthase (eNOS) Uncoupling on Leukocyte-Endothelial Interactions in Rat Mesenteric Postcapillary Venules
【24h】

The Effects of Protein Kinase C (PKC) Epsilon Peptide Regulation on Endothelial Nitric Oxide Synthase (eNOS) Uncoupling on Leukocyte-Endothelial Interactions in Rat Mesenteric Postcapillary Venules

机译:蛋白激酶C(PKC)ε肽调节对大鼠肠系膜后血管白细胞内皮相互作用的内皮酰基氧化酶(ENOS)的影响

获取原文

摘要

Endotheiial-derived nitric oxide (NO) is essential in the regulation of blood pressure and promotes an antithrombotic surface which attenuates leukocyte-endothelial interactions associated with vascular injury. eNOS produces NO from L-arginine in the presence of essential cofactor tetrahydrobiopterin (BH4). When BH4 is oxidized to dihydrobiopterin (BH2), the ratio of BH2/BH4 is increased during vascular injury and promotes eNOS uncoupling, causing eNOS to produce superoxide (SO) instead of NO [1]. However, the role of BH2 to induce eNOS uncoupling and promote leukocyte-endothelial interactions in mesenteric circulation has no1 been characterized in vivo. Moreover, the role of compounds that can increase or decrease eNOS activity in the presence of an increased BH2/BH4 ratio has yet to be determined. PKC epsilon (PKC ε) positively regulates eNOS activity via phosphorylation of serine 1177. Cell-permeable myristoylated (Myr) PKC e peptide activator (PKC e+) or inhibitor (PKC s-) are known to increase or decrease NO release in vitro, respectively [2]. The effect of PKC ε+ is known to be inhibited with classical NOS inhibitors, such as N~G -nitro-L-arginine methyl estet (L-NAME). However, the effect of PKC ε+ or PKC ε- to exacerbate or attenuate BH2-inducec leukocyte-endothelial interactions has not yet been determined.
机译:内皮衍生的一氧化氮(NO)对于调节血压并促进抗血栓形成,其衰减与血管损伤相关的白细胞 - 内皮相互作用。在必需的辅因子四氢萘屈绝素(BH4)的存在下,烯eN在L-精氨酸中产生NO。当BH4被氧化成二氢螺旋蛋白(BH2)时,在血管损伤期间BH2 / BH4的比率增加,促进烯烯烯替换,导致ENOS制备超氧化物(SO)而不是NO [1]。然而,BH2在肠系膜循环中诱导eNOS诱导和促进白细胞 - 内皮相互作用的作用在体内表征了NO1。此外,在存在增加的BH 2 / BH4比存在下,可以增加或减少eNOS活性的化合物的作用尚未确定。 PKC Epsilon(PKCε)通过丝氨酸1177的磷酸化来呈正调节eNOS活性。已知细胞可渗透的肌脲(MYR)PKC E肽活化剂(PKC E +)或抑制剂(PKC S-)分别在体外不释放[2]。已知PKCε+的效果被典型的NOS抑制剂抑制,例如N〜G-NITRO-L-精氨酸甲基酯(L-名称)。然而,尚未确定PKCε+或PKCε-加剧或衰减BH2-INDUCEC白细胞 - 内皮相互作用的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号